Literature DB >> 21160496

Genotype-phenotype correlations among pachyonychia congenita patients with K16 mutations.

Teresa Fu1, Sancy A Leachman, Neil J Wilson, Frances J D Smith, Mary E Schwartz, Jean Y Tang.   

Abstract

Pachyonychia congenita (PC) is a rare, autosomal dominant keratin disorder caused by mutations in four genes (KRT6A, KRT6B, KRT16, or KRT17). The International PC Research Registry is a database with information on patients' symptoms as well as genotypes. We sought to describe the heterogeneity of clinical symptoms and to investigate possible genotype-phenotype correlations in patients with two types of K16 mutations, p.Asn125 and p.Arg127, causing the PC-16 subtype of PC. We found that clinical symptoms depended on the type of amino-acid substitution. Patients with p.Asn125Asp and p.Arg127Pro mutations exhibited more severe disease than patients carrying p.Asn125Ser and p.Arg127Cys mutations in terms of age of onset of symptoms, extent of nail involvement, and impact on daily quality of life. We speculate that amino-acid substitutions causing larger, more disruptive changes to the K16 protein structure, such as a change in amino-acid charge in the p.Asn125Asp mutation or a bulky proline substitution in the p.Arg127Pro mutation, may also lead to more severe disease phenotypes. The variation in phenotypes seen with different substitutions at the same mutation site suggests a genotype-phenotype correlation. Knowledge of the exact gene defect is likely to assist in predicting disease prognosis and clinical management.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21160496      PMCID: PMC3775566          DOI: 10.1038/jid.2010.373

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Pachyonychia congenita: mutations and clinical presentations.

Authors:  C S Munro
Journal:  Br J Dermatol       Date:  2001-05       Impact factor: 9.302

2.  Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses.

Authors:  P M Steinert; J M Yang; S J Bale; J G Compton
Journal:  Biochem Biophys Res Commun       Date:  1993-12-15       Impact factor: 3.575

Review 3.  Clinical and pathological features of pachyonychia congenita.

Authors:  Sancy A Leachman; Roger L Kaspar; Philip Fleckman; Scott R Florell; Frances J D Smith; W H Irwin McLean; Declan P Lunny; Leonard M Milstone; Maurice A M van Steensel; Colin S Munro; Edel A O'Toole; Julide T Celebi; Aleksej Kansky; E Birgitte Lane
Journal:  J Investig Dermatol Symp Proc       Date:  2005-10

Review 4.  The genetic basis of pachyonychia congenita.

Authors:  Frances J D Smith; Haihui Liao; Andrew J Cassidy; Arlene Stewart; Kevin J Hamill; Pamela Wood; Iris Joval; Maurice A M van Steensel; Erik Björck; Faith Callif-Daley; Gerald Pals; Paul Collins; Sancy A Leachman; Colin S Munro; W H Irwin McLean
Journal:  J Investig Dermatol Symp Proc       Date:  2005-10

5.  Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex.

Authors:  F J Smith; L D Corden; E L Rugg; R Ratnavel; I M Leigh; C Moss; M J Tidman; D Hohl; M Huber; L Kunkeler; C S Munro; E B Lane; W H McLean
Journal:  J Invest Dermatol       Date:  1997-02       Impact factor: 8.551

6.  Novel proline substitution mutations in keratin 16 in two cases of pachyonychia congenita type 1.

Authors:  F J Smith; M Del Monaco; P M Steijlen; C S Munro; M Morvay; C M Coleman; F J Rietveld; J Uitto; W H McLean
Journal:  Br J Dermatol       Date:  1999-12       Impact factor: 9.302

7.  Alpha-helix stability in proteins. I. Empirical correlations concerning substitution of side-chains at the N and C-caps and the replacement of alanine by glycine or serine at solvent-exposed surfaces.

Authors:  L Serrano; J Sancho; M Hirshberg; A R Fersht
Journal:  J Mol Biol       Date:  1992-09-20       Impact factor: 5.469

8.  Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families.

Authors:  M K Shamsher; H A Navsaria; H P Stevens; R C Ratnavel; P E Purkis; D P Kelsell; W H McLean; L J Cook; W A Griffiths; S Gschmeissner
Journal:  Hum Mol Genet       Date:  1995-10       Impact factor: 6.150

9.  Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2.

Authors:  S P Covello; F J Smith; J H Sillevis Smitt; A S Paller; C S Munro; M F Jonkman; J Uitto; W H McLean
Journal:  Br J Dermatol       Date:  1998-09       Impact factor: 9.302

10.  A large mutational study in pachyonychia congenita.

Authors:  Neil J Wilson; Sancy A Leachman; C David Hansen; Alexandra C McMullan; Leonard M Milstone; Mary E Schwartz; W H Irwin McLean; Peter R Hull; Frances J D Smith
Journal:  J Invest Dermatol       Date:  2011-02-17       Impact factor: 8.551

  10 in total
  15 in total

1.  Altered keratinocyte differentiation is an early driver of keratin mutation-based palmoplantar keratoderma.

Authors:  Abigail G Zieman; Brian G Poll; Jingqun Ma; Pierre A Coulombe
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

2.  Mutation p.Leu128Pro in the 1A domain of K16 causes pachyonychia congenita with focal palmoplantar keratoderma in a Chinese family.

Authors:  Limeng Dai; Jun Wu; Hong Guo; Yangming Huang; Kun Zhang; Dan Liu; Liyuan Fu; Yuanyuan Wu; Xingying Guan; Yun Bai; Qiong Liao
Journal:  Eur J Pediatr       Date:  2013-12-20       Impact factor: 3.183

Review 3.  Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment.

Authors:  A G Zieman; P A Coulombe
Journal:  Br J Dermatol       Date:  2019-07-24       Impact factor: 9.302

4.  First Report of Pachyonychia Congenita Type PC-K6a in the Romanian Population.

Authors:  Anca Chiriac; Cristina Rusu; Alina Murgu; Anca E Chiriac; Neil J Wilson; Frances J D Smith
Journal:  Maedica (Buchar)       Date:  2017-06

5.  Gene expression profiling in pachyonychia congenita skin.

Authors:  Yu-An Cao; Robyn P Hickerson; Brandon L Seegmiller; Dmitry Grapov; Maren M Gross; Marc R Bessette; Brett S Phinney; Manuel A Flores; Tycho J Speaker; Annaleen Vermeulen; Albert A Bravo; Anna L Bruckner; Leonard M Milstone; Mary E Schwartz; Robert H Rice; Roger L Kaspar
Journal:  J Dermatol Sci       Date:  2015-01-14       Impact factor: 4.563

6.  Distinctions in the Management, Patient Impact, and Clinical Profiles of Pachyonychia Congenita Subtypes.

Authors:  Albert G Wu; Shari R Lipner
Journal:  Skin Appendage Disord       Date:  2021-02-05

7.  Pachyonychia Congenita (K16) with Unusual Features and Good Response to Acitretin.

Authors:  Fahad Almutawa; Thusanth Thusaringam; Kevin Watters; Tenzin Gayden; Nada Jabado; Denis Sasseville
Journal:  Case Rep Dermatol       Date:  2015-08-19

8.  Genotype‒Structurotype‒Phenotype Correlations in Patients with Pachyonychia Congenita.

Authors:  Tiffany T Wu; Sherif A Eldirany; Christopher G Bunick; Joyce M C Teng
Journal:  J Invest Dermatol       Date:  2021-06-08       Impact factor: 8.551

9.  Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders.

Authors:  Juliane C Lessard; Pierre A Coulombe
Journal:  J Invest Dermatol       Date:  2012-02-16       Impact factor: 8.551

10.  Report of the 10th Annual International Pachyonychia Congenita Consortium Meeting.

Authors:  Maurice A M van Steensel; Pierre A Coulombe; Roger L Kaspar; Leonard M Milstone; Irwin W H McLean; Dennis R Roop; Frances J D Smith; Eli Sprecher; Mary E Schwartz
Journal:  J Invest Dermatol       Date:  2014-03       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.